Activation of peroxisome proliferator-activated receptor a in human endothelial cells increases plasminogen activator inhibitor type-1 expression

被引:0
|
作者
Ye, P [1 ]
Hu, XH
Liu, YX
Zhao, YL
机构
[1] Chinese Peoples Liberat Army Gen Hosp, Dept Geriatr Cardiol, Beijing 100853, Peoples R China
[2] Acad Mil Med Sci, PLA, Beijing 100853, Peoples R China
关键词
peroxisome proliferator-activated receptors; plasminogen activator inhibitor 1; umbilical veins;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective To investigate the effect of peroxisome proliferator-activated receptors (PPARs) activators on plasminogen activator inhibitor 1 (PAI-1) expression in human umbilical vein endothelial cells and elucidate a possible mechanism. Methods Human umbilical vein endothelial cells (HUVECs) were obtained from normal fetus, and cultured conventionally. Then the HUVEC were exposed to fatty acids and prostaglandin J(2) in varying concentrations with fresh media. RT-PCR and ELISA were used to determine the expression of PPAR and PAI-1 in HUVECs. Transient co-transfection of PAI-1 promoter and PPARalpha gene or PPARgamma gene to ECV304 was performed. Results PPARalpha, PPARdelta and PPARgamma mRNA in HUVECs were detected by RT-PCR. Treatment of HUVECs with PPARalpha and PPARgamma activators-linolenic acid, linoleic acid, oleic acid and prostaglandin. J2, but not with stearic acid could augment PAI-1 mRNA expression and protein secretion in a concentration-dependent manner. Proportional induction of PAI-1 promoter activity was observed through increasing amounts of PPARalpha DNA in HUVECs through a transient gene transfection assay, although the mRNA expression of the 3 subtypes of PPAR with their activators were not changed compared with controls. Conclusions HUVECs express PPARs, PPARs activators may increase PAI-1 expression in endothelial cells (EC). Although PPARs expression was not enhanced after being stimulated by their activators in EC, the functionally active PPARalpha is probably involved in regulating PAI-1 expression in EC.
引用
收藏
页码:29 / 33
页数:5
相关论文
共 50 条
  • [41] Urokinase-type plasminogen activator and plasminogen activator inhibitor type-1 is increased by interleukin-33 in human endothelial cells
    Demyanets, S.
    Stojkovic, S.
    Kaun, C.
    Lemberger, C. E.
    de Martin, R.
    Maurer, G.
    Huber, K.
    Wojta, J.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2012, 10 (06) : E13 - E13
  • [42] Oxidized LDL regulates vascular endothelial growth factor expression in human macrophages and endothelial cells through activation of peroxisome proliferator-activated receptor-γ
    Inoue, M
    Itoh, H
    Tanaka, T
    Chun, TH
    Doi, K
    Fukunaga, Y
    Sawada, N
    Yamshita, J
    Masatsugu, K
    Saito, T
    Sakaguchi, S
    Sone, M
    Yamahara, K
    Yurugi, T
    Nakao, K
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2001, 21 (04) : 560 - 566
  • [43] Peroxisome proliferator-activated receptor δ(PPAR δ) activation increases both viability and attachment of human proximal tubule cells.
    Letavernier, E
    Perez, J
    Peltier, J
    Bellocq, A
    Fouqueray, B
    Baud, L
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 271A - 271A
  • [44] Chronic transplant nephropathy (CTN) is associated with increased plasminogen activator inhibitor-1 (PAI-1) and peroxisome proliferator-activated receptor-γ (PPARγ) expression
    Revelo, MP
    Federspiel, CF
    Helderman, HJ
    Fogo, AB
    LABORATORY INVESTIGATION, 2002, 82 (01) : 279A - 280A
  • [45] Activation of peroxisome proliferator-activated receptor α increases the expression and activity of microsomal triglyceride transfer protein in the liver
    Améen, C
    Edvardsson, U
    Ljungberg, A
    Asp, L
    Åkerblad, P
    Tuneld, A
    Olofsson, SO
    Lindén, D
    Oscarsson, J
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (02) : 1224 - 1229
  • [46] Chronic transplant nephropathy (CTN) is associated with increased plasminogen activator inhibitor-1 (PAI-1) and peroxisome proliferator-activated receptor-γ (PPARγ) expression
    Revelo, MP
    Federspiel, CF
    Helderman, HJ
    Fogo, AB
    MODERN PATHOLOGY, 2002, 15 (01) : 279A - 280A
  • [47] Expression of peroxisome proliferator-activated receptor γ (PPARγ) in normal human pancreatic islet cells
    Dubois, M
    Pattou, F
    Kerr-Conte, J
    Gmyr, V
    Vandewalle, B
    Desreumaux, P
    Auwerx, J
    Schoonjans, K
    Lefebvre, J
    DIABETOLOGIA, 2000, 43 (09) : 1165 - 1169
  • [48] Expression of peroxisome proliferator-activated receptor γ (PPARγ) in normal human pancreatic islet cells
    M. Dubois
    F. Pattou
    J. Kerr-Conte
    V. Gmyr
    B. Vandewalle
    P. Desreumaux
    J. Auwerx
    K. Schoonjans
    J. Lefebvre
    Diabetologia, 2000, 43 : 1165 - 1169
  • [49] INHIBITION OF ENDOTHELIAL EXPRESSION OF TYPE-1 PLASMINOGEN-ACTIVATOR INHIBITOR BY GEMFIBROZIL
    FUJII, S
    SOBEL, BE
    CIRCULATION, 1992, 86 (04) : 741 - 741
  • [50] Peroxisome Proliferator-Activated Receptorγ Agonist Rosiglitazone Increases Expression of Lipin-1 in Adipocytes
    Kim, Jina
    Han, Dong Cho
    Kwon, Byoung-Mog
    FASEB JOURNAL, 2010, 24